Affiliation: Phnom Penh
- Natural polymorphisms of HIV-1 CRF01_AE integrase coding region in ARV-naïve individuals in Cambodia, Thailand and Vietnam: an ANRS AC12 working group studyJanin Nouhin
Institut Pasteur du Cambodge, Laboratoire VIH Hepatites, Phnom Penh, Cambodia
Infect Genet Evol 11:38-43. 2011..If this substitution is confirmed to compromise the virologic response to raltegravir, further studies will be needed to better assess the prevalence of this substitution among CRF01_AE virus...
- Low prevalence of drug resistance transmitted virus in HIV Type 1-infected ARV-naive patients in CambodiaJanin Nouhin
HIV Hepatitis Laboratory, Pasteur Institute of Cambodia, Phnom Penh, Cambodia
AIDS Res Hum Retroviruses 25:543-5. 2009..04-8.04%) prevalence of transmitted drug-resistant strains in drug-naive patients was low in our study. Surveys of drug-resistant transmitted viruses should be regularly performed regarding the increasing access to HAART in Cambodia...
- High efficacy of lopinavir/r-based second-line antiretroviral treatment after 24 months of follow up at ESTHER/Calmette Hospital in Phnom Penh, CambodiaLaurent Ferradini
Family Health International, Phnom Penh, Cambodia
J Int AIDS Soc 14:14. 2011..We describe the outcomes after 24 months for patients on LPV/r-based second-line regimens followed up by the ESTHER programme in Phnom Penh, Cambodia...
- Effectiveness of highly active antiretroviral therapy in HIV-positive children: evaluation at 12 months in a routine program in CambodiaBart Janssens
Medecins Sans Frontieres, Phnom Penh, Cambodia
Pediatrics 120:e1134-40. 2007..We aimed to describe the clinical, immunologic, and virologic outcomes of pediatric patients with >12 months of highly active antiretroviral therapy in 2 routine programs in Cambodia...
- Evaluation of a boosted-p24 antigen assay for the early diagnosis of pediatric HIV-1 infection in CambodiaJanin Nouhin
Institut Pasteur du Cambodge, Phnom Penh, Cambodia
Am J Trop Med Hyg 75:1103-5. 2006..We observed that boosted-p24-antigen profile assay, with performances similar to viral cultures and costs similar to DNA-PCR, is easier to perform and could readily be set up in resource-poor settings...